Asset Details
MbrlCatalogueTitleDetail
Targeting QseC Signaling and Virulence for Antibiotic Development
/ Anti-Bacterial Agents - administration & dosage
/ Anti-Bacterial Agents - pharmacology
/ Anti-Bacterial Agents - therapeutic use
/ Antibiotics. Antiinfectious agents. Antiparasitic agents
/ Bacteria
/ Biological and medical sciences
/ drugs
/ Enterohemorrhagic Escherichia coli - drug effects
/ Enterohemorrhagic Escherichia coli - genetics
/ Enterohemorrhagic Escherichia coli - metabolism
/ Enterohemorrhagic Escherichia coli - pathogenicity
/ Escherichia coli Infections - drug therapy
/ Escherichia coli Proteins - antagonists & inhibitors
/ Escherichia coli Proteins - genetics
/ Escherichia coli Proteins - metabolism
/ Francisella tularensis - drug effects
/ Francisella tularensis - genetics
/ Francisella tularensis - metabolism
/ Francisella tularensis - pathogenicity
/ Gene Expression Regulation, Bacterial - drug effects
/ Genes
/ Gram-Negative Bacterial Infections - drug therapy
/ Liver
/ Mice
/ Pharmacology. Drug treatments
/ phosphotransferases (kinases)
/ Protein Kinases - metabolism
/ Rabbits
/ Salmonella Infections, Animal - drug therapy
/ Salmonella typhimurium - drug effects
/ Salmonella typhimurium - genetics
/ Salmonella typhimurium - metabolism
/ Salmonella typhimurium - pathogenicity
/ Sensors
/ Signal Transduction - drug effects
/ Spleen
/ Sulfonamides - administration & dosage
/ Sulfonamides - therapeutic use
/ toxicity
MBRLCatalogueRelatedBooks
Related Items
Related Items